Mazabraud Yann 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Mazabraud Yann
EVP, Head of International
Transactions
- Award
Stock Options (Right to Buy)
[F1]2026-03-02+35,000→ 35,000 totalExercise: $94.94Exp: 2036-03-01→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The stock options were granted on March 2, 2026. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
Signature
/s/ Stephen Vander Stoep, attorney-in-fact for Yann Mazabraud|2026-03-04